| Kimeragen,
Inc., is a privately held company headquartered in Newtown, PA engaged in the
discovery, development and marketing of unique products for human health, plant and
animal/veterinary applications. The company is developing chimeraplasty as an enabling
technology for three distinct business areas: pharmaceuticals to repair genetic
abnormalities implicated in a broad array of human diseases; plants and industrial
products to enhance genetic traits in plants; genomic and transgenic animal technologies
aimed at developing higher value applications and products for human health and veterinary
care. Kimeragen plans to commercialize many of those applications through partnerships
with global leaders in these fields. |
